A 10-Week Study Evaluating the Efficacy And Safety of PD 0332334 for the Treatment of Generalized Anxiety Disorder

Status:
Completed

Trial end date:
2008-12-01

Target enrollment:

Participant gender:

This study will evaluate the efficacy and safety of PD 0332334 for the treatment of generalized anxiety disorder.

Phase 3

Pfizer